Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from Lilly's ...
Hosted on MSN
Eli Lilly Cuts Ties with CVS as Employee Pharmacy Provider After Weight-Loss Drug Snub: Report
Eli Lilly (NYSE:LLY) has decided to end its partnership with CVS Health (NYSE:CVS) as the pharmacy benefits provider for its U.S. employees, following CVS’s decision to drop coverage of Lilly’s weight ...
Eli Lilly sued Strive Pharmacy and Strive Specialties on Oct. 22 in Arizona District Court over allegedly false and misleading advertising claims about compounded tirzepatide products. The complaint, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback